Miao Zhang
Partner
Miao Zhang’s practice focuses on equity capital market transactions and general corporate matters, including initial public offerings on the Hong Kong Stock Exchange, pre-IPO investments, PIPE transactions involving Hong Kong-listed clients, and compliance and general corporate matters.
Miao joined the firm in 2011 and became partner in 2023.
Notable Experience
Notable Experience
OneConnect in its dual primary listing by introduction on the Main Board of the Hong Kong Stock Exchange.
The underwriters in JD Logistic Inc.’s $3.2 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.
The underwriters in JD Health International Inc.’s $3.5 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.
Huazhu Group in its $783 million SEC-registered offering and secondary listing in Hong Kong.
Topsports International Holdings Limited in its HK$9 billion IPO and listing on the Main Board of the Hong Kong Stock Exchange.
Hansoh Pharmaceutical Group Company Limited in its HK$9.04 billion IPO and listing on the Main Board of the Hong Kong Stock Exchange.
Dali Foods Group in its HK$8.87 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.
The underwriters in WH Group’s $2.36 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.
Hospital Corporation of China Limited in its HK$491 million global offering and listing on the Main Board Hong Kong Stock Exchange.
China Railway Construction Corporation on its $2.6 billion IPO and listing on the Main Board of the Hong Kong Stock Exchange.
China Coal Energy Company Limited on its $1.96 billion IPO and listing on the Main Board of the Hong Kong Stock Exchange.
Lenovo Group in its $750 million notes offering and concurrent U.S. exclusionary waterfall tender offer, and $1.5 billion combined fixed-rate notes and perpetual securities offerings.
CITIC Securities Company in the establishment of its $3 billion MTN program through CITIC Securities Finance MTN Co., a finance subsidiary, and subsequent $650 million Reg S takedown.
PETRONAS and its finance subsidiary, PETRONAS Capital Limited, in the establishment of a $15 billion GMTN program; a Rule 144A/Reg S offering of three tranches of notes under the GMTN program totaling $3.75 billion; and the concurrent parallel issuance of $1.25 billion sharia-compliant trust certificates under a sukuk structure.
Temasek in its equity investments in Onewo Inc. and China Tourism Group Duty Free Corporation Limited.
Primavera Capital Group in its investment in Ant Group Co. and its subsidiary.
TPG Asia in its equity investment in a subsidiary of Lee’s Pharmaceutical Holdings and in its equity investment in Li Ning Company Limited via the purchase of share and subscription of convertible bonds.
KKR in its investment in China Outfitters Holdings Limited.
DCP Capital in its pre-IPO investment in an ecological construction company.
Hony Capital on its pre-IPO investments in iMab and in China Rongzhong Financial Holdings Company Limited, and in its investment in PCCW International OTT (Cayman Islands) Holding Limited.
China Life Insurance in its purchase of all the shares of China Guangfa Bank held by Citigroup and IBM Credit.
China Pharmaceutical Group on its very substantial acquisition and a connected transaction.
Various Hong Kong-listed issuers on their securities-related transactions and general compliance and regulatory matters.